GoHealth's Investment Story Reshaped by Updated Analyst Assumptions

GoHealth's fair value estimate has been lowered from $17.20 to $14.00 due to mixed financial results, slight changes in the discount rate, and sector-wide uncertainties. Analysts weigh the company's proactive steps to improve its financial foundation and strategic positioning, but remain cautious due to valuation and broader industry factors. The revised price target reflects increased confidence, but a neutral stance suggests that upside may be limited.